Sarepta agrees to FDA’s black box warning and announces major restructuring, including job cuts and cost-saving measures to meet 2027 goals.
Latest Ratings for SRPT
DateFirmActionFromTo Mar 2022Morgan StanleyMaintainsEqual-Weight Mar 2022RBC CapitalMaintainsOutperform Feb 2022Morgan StanleyMaintainsEqual-Weight